Drug Discovery Patent Filings Span Protein Degradation, Ion Channels, and Emerging Targets
Feb 25, 2025
Monthly patent reviews from April through December 2025 highlight notable drug discovery IP disclosures across targeted protein degradation, small molecule modulators, and emerging therapeutic targets in oncology, immunology, and neurology.